THTX

THTX

USD

Theratechnologies Inc. Common Shares

$2.770-0.150 (-5.137%)

Real-time Price

Healthcare
Biotechnology
Canada

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$2.920

High

$2.950

Low

$2.750

Volume

0.04M

Company Fundamentals

Market Cap

128.2M

Industry

Biotechnology

Country

Canada

Trading Stats

Avg Volume

3.04M

Exchange

NCM

Currency

USD

52-Week Range

Low $1.08Current $2.770High $3.13

Related News

GlobeNewswire

Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV

VAMOS analysis highlights link between EVAF and reduced muscle quality Case series reports success with combination tesamorelin/GLP-1 receptor agonist therapy MONTREAL, May 02, 2025 (GLOBE NEWSWIRE) --

View more
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
GlobeNewswire

Theratechnologies Provides Update on Sale Process

MONTREAL, April 15, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a commercial-stage biopharmaceutical company, today announced that following careful

View more
Theratechnologies Provides Update on Sale Process
BusinessWire

Soleus Capital Issues Letter to The Board of Theratechnologies

Soleus Capital Management, L.P. ("Soleus Capital"), a healthcare investment firm which owns in excess of 10% of the stock of Theratechnologies Inc. (NASDAQ:THTX) (the "Company"), today sent a letter to the Board of

View more
Soleus Capital Issues Letter to The Board of Theratechnologies
GlobeNewswire

Theratechnologies Responds to Future Pak's Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company

MONTREAL, April 11, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a commercial-stage biopharmaceutical company, wishes to address its shareholders in

View more
Theratechnologies Responds to Future Pak's Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company
BusinessWire

Future Pak Submits Proposals to Acquire Theratechnologies Inc., Offering up to $255 Million in Total Value

Future Pak, LLC ("Future Pak") today announced that it has submitted two formal proposals since January to acquire all outstanding shares of common stock of Theratechnologies Inc. ("Theratechnologies") (NASDAQ:THTX).

View more
Future Pak Submits Proposals to Acquire Theratechnologies Inc., Offering up to $255 Million in Total Value